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Background
In Serbia in general there are several ways to obtain neces-
sary information on various drugs. Medical and pharma-
ceutical professionals gather information from the
National Agency of Drugs and Medical Devices or from
various publications such as British National Fromulary,
Physicians Drug Reference etc. The general population
can obtain information from their general practicioner
(GP) or pharmacist. At the Department of Pharmacology
and Clinical Pharmacology, Medical Faculty of Novi Sad,
there exists a Drug Information Unit, a regional center
offering drug information to both professionals and the
general population in Vojvodina (approximately 1,600,000
inhabitants).
Methods
The client can require information by phone (more than
99.5% of all requests) or by e-mail. Interns in Clinical
Pharmacology collect necessary data regarding the thera-
peutic problem (age and sex of the patient, other drugs
taken, present diseases etc.). After solving the problem
using the electronic databases or hardcopy sources, and
upon the approval from the senior clinical pharmacologist,
interns deliver the information to the client (both by
phone and e-mail).
Results
About 3% of all requests are from the general population
(usually questions on interactions, side effects, dosing and
administration); the remaining requests are from health
(20% from GPs, and 80% from specialists) or pharmaceuti-
cal professionals. Almost 30% of all of the requests of the
health professionals are regarding possible drug–drug or
drug–disease interactions. About 12% of requests are
related to side effects of the administered drug. Pregnancy
and lactation are subjects of interest in 15% of the overall
number of requests. Maximal doses allowed and posology
have a share of about 11%. The remaining information is
concerning the pharmacokinetics of the drugs, first line
drugs for certain diseases, dosing in children etc.
Conclusions
It can be concluded that the Drug Information Unit is a
useful source of information for both professionals and
the general population offering various information on
different topics related to drugs.
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